Cervical Cancer — Overview, Symptoms, Treatments, and Other Resources.
Information on Cervical Cancer from the National Library of Medicine
The cervix is the lower part of the uterus, the place where a baby grows during pregnancy. Cervical cancer is caused by several types of a virus called human papillomaviruses (HPV). The virus spreads through sexual contact. Most women's bodies are able to fight HPV infection. But sometimes the virus leads to cancer. You're at higher risk if you smoke, have many children, use birth control pills for a long time, or have HIV infection. Read more at the national Library of Medicine, National Institutes of Health.
Cervical Cancer - MayoClinic.com
Information on cervical cancer from MayoClinic.com.
Cervical Cancer Information from the National Cancer Institute
Cancer that forms in tissues of the cervix (the organ connecting the uterus and vagina). It is usually a slow-growing cancer that may not have symptoms but can be found with regular Pap tests (a procedure in which cells are scraped from the cervix and looked at under a microscope). Cervical cancer is almost always caused by human papillomavirus (HPV) infection. Read more at the National Cancer Institute.
Cancer Risk- Understanding the Puzzle of Cervical Cancer.
An interactive tool for assessing an individual's risk factors for cervical cancer from the National Cancer Institute.
An Interactive DES Self-Assessment Guide.
An interactive tool to help women (and men) born between 1938-1971, and women who gave birth during those years assess the likelihood that they were exposed to DES (a synthetic estrogen Diethylstilbestrol), a risk factor for cervical cancer presented by the Centers for Disease Control.
Podcast: Cancer Newsline - Cervical Cancer and Fertility Preservation
A 14 minute podcast discussing a surgical procedure to help preserve of fertility in women with cervical cancer from the MD Anderson Cancer Clinic.
Video: Cervical Cancer HPV Update
A presentation by Dr. Joseph P. Conner at the IME video Library.
The National Comprehensive Cancer Network cervical cancer guidelines.
The NCCN cervical cancer guidelines include the management of squamous cell carcinoma, adenosquamous carcinoma, and adenocarcinoma of the cervix. Read the guidelines for healthcare professionals at the National Cancer Care Network (free registration required for access).
American Cancer Society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors.
Guidelines: To address the use of prophylactic human papillomavirus (HPV) vaccines, including who should be vaccinated and at what age, as well as provide a summary of policy and implementation issues. More at the National Guideline Clearinghouse.
Initial management of abnormal cervical cytology (Pap smear) and HPV testing.
GUIDELINE OBJECTIVE(S): To provide recommendations for appropriate clinical follow-up for women who undergo cervical cytologic analysis (Pap smear) and receive an abnormal cervical cytology result; To provide recommendations regarding colposcopy with endocervical curettage (ECC) or loop electrosurgical excision procedure (LEEP) for women who are diagnosed with a high grade abnormal cervical cytology result; To reduce the psychological distress and increase the knowledge of women who are notified of a cervical cytology abnormality. See major guidelines at National Guideline Clearinghouse.
Abstract: Human Papillomavirus and Vaccination.
Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the United States. Modeling estimates suggest that more than 80% of sexually active women will have acquired genital HPV by age 50 years. Although most infections are transient and asymptomatic, persistent infection with high-risk types of HPV can lead to precancerous lesions and progress to cancer. In June 2006, the US Food and Drug Administration licensed the first vaccine to prevent cervical cancers and other diseases in women. This quadrivalent vaccine protects against HPV-6, HPV-11, HPV-16, and HPV-18, which are responsible for 70% of cervical cancers and 90% of genital warts. Several studies have been published examining the vaccine's efficacy, duration, immunogenicity, and safety. Questions and controversy remain regarding mandatory vaccination, need for booster doses, and cost-effectiveness. Full text available free through PubMed.
Abstract: Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities.
Objectives- To examine the effectiveness of cytological surveillance in primary care compared with immediate referral for colposcopic examination in women with low grade abnormal results on cervical cytology tests. Full text available free from PubMed.
Abstract: A case-control study of robot-assisted type III radical hysterectomy with pelvic lymph node dissection compared with open radical hysterectomy.
OBJECTIVE: The purpose of this study was to compare robotically assisted hysterectomy (RAH) with open (ORH) type III radical hysterectomy in the treatment of early-stage cervical cancer. STUDY DESIGN: The outcomes of 51 consecutive patients who underwent RAH were compared with the outcomes of 49 patients who underwent ORH. See Abstract at PubMed
Abstract: Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States.
Objective To assess the cost effectiveness of including preadolescent boys in a routine human papillomavirus (HPV) vaccination programme for preadolescent girls. Full text free at PubMed.
Abstract: Novel chemotherapy approaches for cervical cancer.
Cancer of the cervix is the second most common malignancy among women worldwide. The last 20 years have lead to numerous advances in the medical management of locally advanced cervical cancer, including preventive vaccination, chemoradiation, and neoadjuvant chemotherapy. See Abstract at PubMed.
Abstract:Loop electrosurgical excision procedure and the risk for preterm birth.
OBJECTIVE: To study whether loop electrosurgical excision procedure (LEEP) conization is associated with preterm birth and to study the effect of cone size on preterm birth. METHODS: This was a retrospective cohort study from Southern Finland conducted from 1997 to 2003, with a follow-up for subsequent births until 2006. See Abstract at PubMed.
Abstract: Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype.
Human papillomavirus (HPV) DNA sequences are associated with the large majority of invasive cervical carcinoma but the role of specific genotype(s) in the outcome of the disease is still debated. To determine the viral epidemiology in the French population of patients and the prognostic value of HPV genotypes in cervical cancer, we performed a retrospective study in 515 patients treated in our Institution from 1985 to 2005. Ninety-six percent of the cases were found associated with HPV DNA whereas 4% remained HPV negative. High-risk HPV 16/18 genotypes were found in 70% of the cases. HPV 18 was more frequently associated with adenocarcinoma (40.6%) than HPV 16 (10.4%) and found in tumours developed in younger women (mean age, 45.8 years) than HPV 16 (48.3 years) or other HPV types (53.6 years). See Abstract at PubMed.
Looking for a Top-Rated
Gynecologist, Obstetrician, or Therapeutic Radiologist?
Consumers' Guide to Top Doctors finds the Doctors Rated Best by other Doctors
To find out who the top doctors are around the country, nonprofit Consumers' CHECKBOOK surveyed roughly 340,000 physicians to tell us which specialists they would want to care for a loved one. The Top Doctors database contains the names of over 23,000 doctors who were mentioned most often. Find top-rated doctors in the fifty largest metropolitan areas, in over thirty-five specialties, and more.
Drawing; Anatomy: The Cervix and Nearby Organs
Source: The Pearl of Wisdom Campaign to Prevent Cervical Cancer.
Downloadable Cervical Cancer Awareness Campaign Poster
Consumers' Guide to Top Doctors finds the Doctors Rated Best by other Doctors in over 30 specialties.
database of 23,000 top-rated physicians by
Doctors database of 23,000 top-rated
(over 35 different fields included) Specialty
Cervical cancer patients - their stories.
Source: National Cervical Cancer Public Education Campaign
Consumers' Guide to Hospitals
Which Hospital Should You Choose (or Avoid)?
What makes the Consumers' Guide to Hospitals so special?
We've got 30 million answers to that question. That's how many hospital records Consumers' CHECKBOOK sifted through to calculate risk-adjusted death rates and adverse-outcome rates, and that's just part of the data used to rate the hospitals. The organization also sent out more than 280,000 questionnaires to physicians in 53 major metropolitan areas in the United States, asking them to rate their local hospitals; checked ratings of the hospitals by surveyed consumers; checked which hospitals were providing recommended tests and procedures for patients with specified medical problems; and more."
AARP The Magazine
Source: National Cervical Cancer Public Education Campaign
Return to the Diseases & Treatments A-Z page